Clinical Application and Choice of Mechanical Circulatory Support Devices in Children

Lu Fangfang,Zhang Wei,Zhu Deming,Zhang Haibo,Xu Zhuoming,Shu Qiang,Wang Wei
DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.2016.06.004
2016-01-01
Abstract:Objective To explore the clinical application of centrifugal ventricular assist device (VAD) and extracorporeal membrane oxygenation (ECMO) at Shanghai Children's Medical Center and summarize the experiences of selecting an ideal method of mechanical circulatory support (MCS) in pediatric cases. Methods From January 2005 to December 2015, 60 cases were support by MCS devices. There were congenital heart defects (n=56) and acute myocarditis (n=4). The mechanical circulatory support devices were used for supporting circulatory functions because of heart failure or arrhythmia. Thirty-two cases were supported with centrifugal VAD (VAD group) and 26 with ECMO (ECMO group) and other 2 cases were started by VAD then transferred to ECMO (VAD-ECMO group). Results The duration for VAD was from 3 to 458 hours. Twenty-two cases were weaned and 20(62.50%) were successfully discharged. The duration of ECMO was from 26 to 498 hours. Sixteen cases were weaned and 14 (53.85%) successfully discharged. None survived in VAD-ECMO group. Bleeding and neurological complications were two major mortal causes. ALCAPA (anomalous origin of coronary artery from pulmonary artery) cases had the biggest ratio in VAD group and the survival rate was 81.82%. Conclusions Pediatric patients with cardiac failure are suitable for VAD and ECMO supports. Cardiac function, respiratory function, age, complications and costs should be considered for selecting from these two methods. Key words: Heart-assist devices; Extracorporeal circulation; Heart Failure
What problem does this paper attempt to address?